These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 262004)

  • 1. [Main histocompatibility HLA system antigens in myasthenia gravis].
    Kastelan A; Jusić A
    Neurologija; 1979; 27(1-4):155-62. PubMed ID: 262004
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical, pathologic and HLA antigen markers of heterogeneity associated with myasthenia gravis].
    Apostolski S; Krstić S; Gospavić J; Miletić V; Lazić D; Stolić I
    Neurologija; 1985; 34(1-4):47-58. PubMed ID: 3836365
    [No Abstract]   [Full Text] [Related]  

  • 3. [Histocompatibility antigens in childhood myasthenia].
    Uhrynowska M
    Neurol Neurochir Pol; 1987; 21(2):119-24. PubMed ID: 3477704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunoreactivity, HL-A antigen frequencies and clinical disease course of myasthenia gravis].
    Gross WL; Krüger J; Stewart U; Häckell U; Kunze K
    Verh Dtsch Ges Inn Med; 1975; 81():1178-81. PubMed ID: 1229431
    [No Abstract]   [Full Text] [Related]  

  • 5. [Subgroups of myasthenia gravis. Association of the early form with HLA B8/DR3].
    Scherbaum WA; Schumm F
    Dtsch Med Wochenschr; 1983 Aug; 108(31-32):1218. PubMed ID: 6575909
    [No Abstract]   [Full Text] [Related]  

  • 6. Familial autoimmune myasthenia gravis.
    Tan JH; Ho KH
    Singapore Med J; 2001 Apr; 42(4):178-9. PubMed ID: 11465320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between acetylcholine receptor antibody titer and HLA-B8 and HLA-DRw3 antigens in myasthenia gravis.
    Keesey J; Naeim F; Lindstrom J; Zeller E; Herrmann C; Walford R
    Trans Am Neurol Assoc; 1978; 103():188-90. PubMed ID: 757055
    [No Abstract]   [Full Text] [Related]  

  • 8. HLA antigens and immunoglobulin allotypes in myasthenia gravis.
    Apolostolski S; Susaković N; Lavrnić S; Stolić I; Trikić R
    Neurologija; 1987; 36(1-4):41-9. PubMed ID: 3509808
    [No Abstract]   [Full Text] [Related]  

  • 9. HLA antigens and susceptibility to myasthenia gravis.
    Matej H; Nowakowska B; Kałamarz M; Paradowski B; Podemski R; Brzecki A
    Arch Immunol Ther Exp (Warsz); 1987; 35(6):795-801. PubMed ID: 3508039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on HLA antigens and cellular and humoral autoimmune phenomena in patients with myasthenia gravis.
    Gross WL; Krüger J; Gröschel-Stewart U; Friedrich H; Kunze K
    Clin Exp Immunol; 1977 Jan; 27(1):48-54. PubMed ID: 849650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of sex-related and HLA antigen-bound genetic factors in myasthenia gravis].
    Gyódi KE; Szohor A; Onody K; Klein M; Petrányi GG; Hollán Z
    Orv Hetil; 1980 Mar; 121(13):749-53. PubMed ID: 7383652
    [No Abstract]   [Full Text] [Related]  

  • 12. [HLA and myasthenia. Subdivision in 3 categories].
    Elchidiac A; Lepage V; Berrih S; Colombani J; Degos L
    Pathol Biol (Paris); 1985 Jan; 33(1):50-4. PubMed ID: 3871932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Myasthenia-multiple sclerosis: a possible pathogenetic relationship?].
    De Meyer F; Maquet JC; Gyselings R
    Rev Med Brux; 1988 Sep; 9(6):321-5. PubMed ID: 3051249
    [No Abstract]   [Full Text] [Related]  

  • 14. HLA, anti-DNA, and complement in myasthenia gravis.
    Christiansen FT; Houliston JB; Dawkins RL
    Muscle Nerve; 1978; 1(6):467-70. PubMed ID: 757869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acquired myasthenia gravis and HLA system].
    Alberca R; Navarro A; Núñez-Roldán A; Wichmann I
    Neurologia; 1987; 2(2):50-3. PubMed ID: 3274070
    [No Abstract]   [Full Text] [Related]  

  • 16. Monoclonal antibody analysis of blood T-cell subsets in myasthenia gravis.
    Skolnik PR; Lisak RP; Zweiman B
    Ann Neurol; 1982 Feb; 11(2):170-6. PubMed ID: 6462101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA genotypes in Turkish patients with myasthenia gravis: comparison with multiple sclerosis patients on the basis of clinical subtypes and demographic features.
    Dönmez B; Ozakbas S; Oktem MA; Gedizlioglu M; Coker I; Genc A; Idiman E
    Hum Immunol; 2004 Jul; 65(7):752-7. PubMed ID: 15301866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial myasthenia gravis: a study of three families.
    Chin D; Gubbay SS
    Clin Exp Neurol; 1985; 21():141-8. PubMed ID: 3843213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA class II antigens and DNA restriction fragment length polymorphism in myasthenia gravis in Japan.
    Morita K; Moriuchi J; Inoko H; Tsuji K; Arimori S
    Ann Neurol; 1991 Feb; 29(2):168-74. PubMed ID: 1672809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiacetylcholine receptor and antinuclear antibodies in myasthenia gravis. Correlation with HLA, sex and Gm.
    Warlow RS; Garlepp M; Feeney D; Kay P; Swanson N; Dawkins RL
    Exp Clin Immunogenet; 1985; 2(3):158-63. PubMed ID: 3917146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.